{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:30:51Z","timestamp":1794853851097,"version":"4.9.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/ncpgasthep0528","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T15:34:35Z","timestamp":1152200075000},"page":"390-407","source":"Crossref","is-referenced-by-count":1470,"title":["Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis"],"prefix":"10.1038","volume":"3","author":[{"given":"R Balfour","family":"Sartor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpgasthep0528_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus Jr","year":"2004","unstructured":"Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504\u20131517","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR2","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0016-5085(03)00385-8","volume":"124","author":"J Halfvarson","year":"2003","unstructured":"Halfvarson J et al. (2003) Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124: 1767\u20131773","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR3","first-page":"401","volume":"21","author":"KA Newman B and Siminovitch","year":"2005","unstructured":"Newman B and Siminovitch KA (2005) Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 21: 401\u2013407","journal-title":"Curr Opin Gastroenterol"},{"key":"BFncpgasthep0528_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrg1607","volume":"6","author":"S Schreiber","year":"2005","unstructured":"Schreiber S et al. (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6: 376\u2013388","journal-title":"Nat Rev Genet"},{"key":"BFncpgasthep0528_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599\u2013603","journal-title":"Nature"},{"key":"BFncpgasthep0528_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603\u2013606","journal-title":"Nature"},{"key":"BFncpgasthep0528_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/gut.2004.062794","volume":"54","author":"E Cario","year":"2005","unstructured":"Cario E (2005) Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54: 1182\u20131193","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/gast.2003.50153","volume":"124","author":"T Hisamatsu","year":"2003","unstructured":"Hisamatsu T et al. (2003) CARD15\/NOD2 functions as an anti-bacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993\u20131000","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR9","doi-asserted-by":"publisher","first-page":"19021","DOI":"10.1074\/jbc.M413776200","volume":"280","author":"N Barnich","year":"2005","unstructured":"Barnich N et al. (2005) GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 280: 19021\u201319026","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0528_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0016-5085(03)00661-9","volume":"125","author":"S Lala","year":"2003","unstructured":"Lala S et al. (2003) Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125: 47\u201357","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"KS Kobayashi","year":"2005","unstructured":"Kobayashi KS et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731\u2013734","journal-title":"Science"},{"key":"BFncpgasthep0528_CR12","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1073\/pnas.0505256102","volume":"102","author":"J Wehkamp","year":"2005","unstructured":"Wehkamp J et al. (2005) Reduced Paneth cell \u03b1-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102: 18129\u201318134","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpgasthep0528_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni1092","volume":"5","author":"T Watanabe","year":"2004","unstructured":"Watanabe T et al. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800\u2013808","journal-title":"Nat Immunol"},{"key":"BFncpgasthep0528_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/gast.2002.30294","volume":"122","author":"A Swidsinski","year":"2002","unstructured":"Swidsinski A et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44\u201354","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ng1339","volume":"36","author":"VD Peltekova","year":"2004","unstructured":"Peltekova VD et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36: 471\u2013475","journal-title":"Nat Genet"},{"key":"BFncpgasthep0528_CR16","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1053\/j.gastro.2005.09.025","volume":"129","author":"CL Noble","year":"2005","unstructured":"Noble CL et al. (2005) The contribution of OCTN1\/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129: 1854\u20131864","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ng1345","volume":"36","author":"M Stoll","year":"2004","unstructured":"Stoll M et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36: 476\u2013480","journal-title":"Nat Genet"},{"key":"BFncpgasthep0528_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/j.gastro.2004.11.019","volume":"128","author":"GT Ho","year":"2005","unstructured":"Ho GT et al. (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128: 288\u2013296","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1086\/379927","volume":"73","author":"SR Brant","year":"2003","unstructured":"Brant SR et al. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73: 1282\u20131292","journal-title":"Am J Hum Genet"},{"key":"BFncpgasthep0528_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0016-5085(00)70210-1","volume":"118","author":"RJ Farrell","year":"2000","unstructured":"Farrell RJ et al. (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118: 279\u2013288","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR21","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","volume":"161","author":"CM Panwala","year":"1998","unstructured":"Panwala CM et al. (1998) A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. J Immunol 161: 5733\u20135744","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2004.11.001","volume":"128","author":"K Sugawara","year":"2005","unstructured":"Sugawara K et al. (2005) Linkage to peroxisome proliferator-activated receptor-\u03b3 in SAMP1\/YitFc mice and in human Crohn's disease. Gastroenterology 128: 351\u2013360","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0016-5085(03)00271-3","volume":"124","author":"L Dubuquoy","year":"2003","unstructured":"Dubuquoy L et al. (2003) Impaired expression of peroxisome proliferator-activated receptor \u03b3 in ulcerative colitis. Gastroenterology 124: 1265\u20131276","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.20041948","volume":"201","author":"C Rousseaux","year":"2005","unstructured":"Rousseaux C et al. (2005) Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-\u03b3. J Exp Med 201: 1205\u20131215","journal-title":"J Exp Med"},{"key":"BFncpgasthep0528_CR25","first-page":"3323","volume":"96","author":"JD Lewis","year":"2001","unstructured":"Lewis JD et al. (2001) An open-label trial of the PPAR-\u03b3 ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 96: 3323\u20133328","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0528_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1172\/JCI7145","volume":"104","author":"CG Su","year":"1999","unstructured":"Su CG et al. (1999) A novel therapy for colitis utilizing PPAR-\u03b3 ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383\u2013389","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","volume":"102","author":"R Duchmann","year":"1995","unstructured":"Duchmann R et al. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102: 448\u2013455","journal-title":"Clin Exp Immunol"},{"key":"BFncpgasthep0528_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","volume":"126","author":"WS Mow","year":"2004","unstructured":"Mow WS et al. (2004) Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126: 414\u2013424","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR et al. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029\u20131035","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR30","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa033402","volume":"351","author":"PJ Mannon","year":"2004","unstructured":"Mannon PJ et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351: 2069\u20132079","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1572-0241.2005.41089.x","volume":"100","author":"K Sawada","year":"2005","unstructured":"Sawada K et al. (2005) Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case\u2013control study with sham apheresis as placebo treatment. Am J Gastroenterol 100: 1362\u20131369","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0528_CR32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","volume":"330","author":"S Lichtiger","year":"1994","unstructured":"Lichtiger S et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841\u20131845","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/B978-012491543-5\/50039-5","volume-title":"In Mucosal Immunology","author":"RB Sartor","year":"2005","unstructured":"Sartor RB and Hoentjen F (2005) Proinflammatory cytokines and signaling pathways in intestinal innate immune cells. In Mucosal Immunology, 681\u2013701 (Eds Mestecky J et al.) Philadelphia: Elsevier"},{"issue":"Suppl 1","key":"BFncpgasthep0528_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1590\/S0074-02762005000900033","volume":"100","author":"TA Reaves","year":"2005","unstructured":"Reaves TA et al. (2005) Neutrophil transepithelial migration: role of Toll-like receptors in mucosal inflammation. Mem Inst Oswaldo Cruz 100 (Suppl 1): 191\u2013198","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"BFncpgasthep0528_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1172\/JCI200519229","volume":"115","author":"LE Smythies","year":"2005","unstructured":"Smythies LE et al. (2005) Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66\u201375","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"R Iwasaki A and Medzhitov","year":"2004","unstructured":"Iwasaki A and Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987\u2013995","journal-title":"Nat Immunol"},{"key":"BFncpgasthep0528_CR37","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","volume":"128","author":"G Jarnerot","year":"2005","unstructured":"Jarnerot G et al. (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128: 1805\u20131811","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm0996-998","volume":"2","author":"MF Neurath","year":"1996","unstructured":"Neurath MF et al. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-\u03baB abrogates established experimental colitis in mice. Nat Med 2: 998\u20131004","journal-title":"Nat Med"},{"key":"BFncpgasthep0528_CR39","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1073\/pnas.0306734101","volume":"101","author":"LJ Egan","year":"2004","unstructured":"Egan LJ et al. (2004) I\u03baB-kinase\u03b2-dependent NF-\u03baB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101: 2452\u20132457","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpgasthep0528_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nm849","volume":"9","author":"LW Chen","year":"2003","unstructured":"Chen LW et al. (2003) The two faces of IKK and NF-\u03baB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia\u2013reperfusion. Nat Med 9: 575\u2013581","journal-title":"Nat Med"},{"key":"BFncpgasthep0528_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00535-004-1492-9","volume":"40","author":"A Araki","year":"2005","unstructured":"Araki A et al. (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40: 16\u201323","journal-title":"J Gastroenterol"},{"key":"BFncpgasthep0528_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S et al. (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229\u2013241","journal-title":"Cell"},{"key":"BFncpgasthep0528_CR43","first-page":"120","volume-title":"Kirsner's Inflammatory Bowel Diseases","author":"RB Sartor","year":"2004","unstructured":"Sartor RB (2004) Animal models of intestinal inflammation. In Kirsner's Inflammatory Bowel Diseases, 120\u2013137 (Eds Sartor RB and Sandborn WJ) Philadelphia: Elsevier"},{"key":"BFncpgasthep0528_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/gast.2002.30308","volume":"122","author":"DM Spencer","year":"2002","unstructured":"Spencer DM et al. (2002) Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122: 94\u2013105","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR45","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1053\/j.gastro.2004.11.053","volume":"128","author":"G Bamias","year":"2005","unstructured":"Bamias G et al. (2005) Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128: 654\u2013666","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"A Kolls JK and Linden","year":"2004","unstructured":"Kolls JK and Linden A (2004). Interleukin-17 family members and inflammation. Immunity 21: 467\u2013476","journal-title":"Immunity"},{"key":"BFncpgasthep0528_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1172\/JCI200317464","volume":"112","author":"C Becker","year":"2003","unstructured":"Becker C et al. (2003) Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 112: 693\u2013706","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino S et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65\u201370","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00054725-200501000-00003","volume":"11","author":"C Schmidt","year":"2005","unstructured":"Schmidt C et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11: 16\u201323","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR50","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D et al. (2006) IL-23 is essential for T-cell mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310\u20131316","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","volume":"128","author":"G Monteleone","year":"2005","unstructured":"Monteleone G et al. (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-\u03b3 production in Crohn's disease. Gastroenterology 128: 687\u2013694","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR52","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.20011956","volume":"195","author":"MF Neurath","year":"2002","unstructured":"Neurath MF et al. (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195: 1129\u20131143","journal-title":"J Exp Med"},{"key":"BFncpgasthep0528_CR53","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","volume":"157","author":"IJ Fuss","year":"1996","unstructured":"Fuss IJ et al. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-\u03b3, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261\u20131270","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR54","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ et al. (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical TH2 response in ulcerative colitis. J Clin Invest 113: 1490\u20131497","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.gastro.2005.05.013","volume":"129","author":"AL Hart","year":"2005","unstructured":"Hart AL et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129: 50\u201365","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1053\/gast.2003.50050","volume":"124","author":"T Totsuka","year":"2003","unstructured":"Totsuka T et al. (2003) Ameliorating effect of anti-inducible co-stimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124: 410\u2013421","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1385\/IR:29:1-3:283","volume":"29","author":"IR Williams","year":"2004","unstructured":"Williams IR (2004) Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol Res 29: 283\u2013292","journal-title":"Immunol Res"},{"key":"BFncpgasthep0528_CR58","doi-asserted-by":"publisher","first-page":"G458","DOI":"10.1152\/ajpgi.00167.2003","volume":"286","author":"N Hosoe","year":"2004","unstructured":"Hosoe N et al. (2004) Demonstration of functional role of TECK\/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am J Physiol Gastrointest Liver Physiol 286: G458\u2013G466","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0528_CR59","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gut.2003.028225","volume":"53","author":"SJ Connor","year":"2004","unstructured":"Connor SJ et al. (2004) CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 53: 1287\u20131294","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa020732","volume":"348","author":"S Ghosh","year":"2003","unstructured":"Ghosh S et al. (2003) Natalizumab for active Crohn's disease. N Engl J Med 348: 24\u201332","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR61","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa042982","volume":"352","author":"BG Feagan","year":"2005","unstructured":"Feagan BG et al. (2005) Treatment of ulcerative colitis with a humanized antibody to the \u03b14\u03b27 integrin. N Engl J Med 352: 2499\u20132507","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR62","doi-asserted-by":"publisher","first-page":"38168","DOI":"10.1074\/jbc.M205737200","volume":"277","author":"D Haller","year":"2002","unstructured":"Haller D et al. (2002) IKK\u03b2 and phosphatidylinositol 3-kinase\/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-\u03baB activation in both primary and intestinal epithelial cell lines. J Biol Chem 277: 38168\u201338178","journal-title":"J Biol Chem"},{"key":"BFncpgasthep0528_CR63","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.4049\/jimmunol.174.5.2990","volume":"174","author":"PA Ruiz","year":"2005","unstructured":"Ruiz PA et al. (2005) IL-10 gene- deficient mice lack TGF \u03b2\/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 174: 2990\u20132999","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR64","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/JCI200420295","volume":"113","author":"MJ Lodes","year":"2004","unstructured":"Lodes MJ et al. (2004) Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest 113: 1296\u20131306","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR65","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","volume":"128","author":"SR Targan","year":"2005","unstructured":"Targan SR et al. (2005) Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128: 2020\u20132028","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR66","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2004-04-1309","volume":"105","author":"F Hoentjen","year":"2005","unstructured":"Hoentjen F et al. (2005) STAT3 regulates NF-\u03baB recruitment to the IL-12 p40 promoter in dendritic cells. Blood 105: 689\u2013696","journal-title":"Blood"},{"key":"BFncpgasthep0528_CR67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI22996","volume":"115","author":"K Katakura","year":"2005","unstructured":"Katakura K et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695\u2013702","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR68","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","volume":"128","author":"SC Kim","year":"2005","unstructured":"Kim SC et al. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891\u2013906","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR69","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","volume":"66","author":"RK Sellon","year":"1998","unstructured":"Sellon RK et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224\u20135231","journal-title":"Infect Immun"},{"key":"BFncpgasthep0528_CR70","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/gut.38.3.365","volume":"38","author":"A Macpherson","year":"1996","unstructured":"Macpherson A et al. (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365\u2013375","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4049\/jimmunol.159.1.44","volume":"159","author":"SL Brandwein","year":"1997","unstructured":"Brandwein SL et al. (1997) Spontaneously colitic C3H\/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 159: 44\u201352","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR72","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/S0016-5085(97)70002-7","volume":"113","author":"E Mizoguchi","year":"1997","unstructured":"Mizoguchi E et al. (1997) Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology 113: 1828\u20131835","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR73","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","volume":"186","author":"A Mizoguchi","year":"1997","unstructured":"Mizoguchi A (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 186: 1749\u20131756","journal-title":"J Exp Med"},{"key":"BFncpgasthep0528_CR74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00281-004-0189-8","volume":"26","author":"P Velazquez","year":"2005","unstructured":"Velazquez P et al. (2005) Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol 26: 453\u2013462","journal-title":"Springer Semin Immunopathol"},{"key":"BFncpgasthep0528_CR75","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.4049\/jimmunol.169.11.6112","volume":"169","author":"Y Cong","year":"2002","unstructured":"Cong Y et al. (2002) Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169: 6112\u20136119","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR76","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/gast.2001.22547","volume":"120","author":"C Veltkamp","year":"2001","unstructured":"Veltkamp C et al. (2001) Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(\u03b526) mice. Gastroenterology 120: 900\u2013913","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR77","first-page":"A512","volume":"128","author":"SC Kim","year":"2005","unstructured":"Kim SC et al. (2005) Different host genetic backgrounds determine disease phenotypes induced by selective bacterial colonization [abstract]. Gastroenterology 128: A512","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1472-765X.2005.01720.x","volume":"41","author":"R Bibiloni","year":"2005","unstructured":"Bibiloni R et al. (2005) Analysis of the large bowel microbiota of colitic mice using PCR\/DGGE. Lett Appl Microbiol 41: 45\u201351","journal-title":"Lett Appl Microbiol"},{"key":"BFncpgasthep0528_CR79","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1053\/j.gastro.2005.11.045","volume":"130","author":"JP Moran","year":"2006","unstructured":"Moran JP et al. (2006) Bifidobacterium animalis causes mild inflammatory bowel disease in interleukin-10 knockout mice [abstract]. Gastroenterology 130: A6","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR80","unstructured":"Holt L et al. (2005) Heat shock protein (HSP) 60 from Bacteroides vulgatus stimulates proinflammatory cytokine production by rat splenocytes [abstract]. Gastroenterology 128: A512"},{"key":"BFncpgasthep0528_CR81","first-page":"138","volume-title":"Kirsner's Inflammatory Bowel Diseases","author":"RB Sartor","year":"2004","unstructured":"Sartor RB (2004) Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In Kirsner's Inflammatory Bowel Diseases, 138\u2013162 (Eds Sartor RB and Sandborn WJ) Philadelphia: Elsevier"},{"key":"BFncpgasthep0528_CR82","unstructured":"Kim SC et al. (2004) Dual-association of gnotobiotic IL-10\u2212\/\u2212 mice with two nonpathogenic commensal bacterial species accelerates colitis [abstract]. Gastroenterology 126: A291"},{"key":"BFncpgasthep0528_CR83","first-page":"A210","volume":"128","author":"RB Tsang J and Sartor","year":"2005","unstructured":"Tsang J and Sartor RB (2005) Effect of diet on colitis in IL-10\u2212\/\u2212 mice [abstract]. Gastroenterology 128: A210","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR84","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/gut.52.3.370","volume":"52","author":"LA Dieleman","year":"2003","unstructured":"Dieleman LA et al. (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52: 370\u2013376","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00054725-200203000-00001","volume":"8","author":"M Schultz","year":"2002","unstructured":"Schultz M et al. (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice. Inflamm Bowel Dis 8: 71\u201380","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR86","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"RB Sartor","year":"2004","unstructured":"Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 126: 1620\u20131633","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR87","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","volume":"100","author":"R Bibiloni","year":"2005","unstructured":"Bibiloni R et al. (2005) VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100: 1539\u20131546","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0528_CR88","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2036.2003.01465.x","volume":"17","author":"J Kuisma","year":"2003","unstructured":"Kuisma J et al. (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17: 509\u2013515","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep0528_CR89","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/gast.2000.9370","volume":"119","author":"P Gionchetti","year":"2000","unstructured":"Gionchetti P et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305\u2013309","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR90","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1053\/gast.2002.1231527","volume":"123","author":"DJ Berg","year":"2002","unstructured":"Berg DJ et al. (2002) Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123: 1527\u20131542","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR91","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/00054725-200411000-00022","volume":"10","author":"DP Perl","year":"2004","unstructured":"Perl DP et al. (2004) Bacterial\u2013metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis 10: 881\u2013883","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR92","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/00054725-200411000-00019","volume":"10","author":"U Birrenbach T and Bocker","year":"2004","unstructured":"Birrenbach T and Bocker U (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10: 848\u2013859","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR93","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bpg.2003.12.003","volume":"18","author":"J Cosnes","year":"2004","unstructured":"Cosnes J (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18: 481\u2013496","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BFncpgasthep0528_CR94","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/gut.2004.055889","volume":"54","author":"RB Sartor","year":"2005","unstructured":"Sartor RB (2005) Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54: 896\u2013898","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR95","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/BF01317078","volume":"29","author":"RJ Chiodini","year":"1984","unstructured":"Chiodini RJ et al. (1984) Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci 29: 1073\u20131079","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep0528_CR96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1590-8658(02)80055-X","volume":"34","author":"I Shafran","year":"2002","unstructured":"Shafran I et al. (2002) Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 34: 22\u201328","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0528_CR97","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1128\/AEM.62.9.3446-3452.1996","volume":"62","author":"D Millar","year":"1996","unstructured":"Millar D et al. (1996) IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Appl Env Microbiol 62: 3446\u20133452","journal-title":"Appl Env Microbiol"},{"key":"BFncpgasthep0528_CR98","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1572-0241.2000.01954.x","volume":"95","author":"SA Naser","year":"2000","unstructured":"Naser SA et al. (2000) Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol 95: 1094\u20131095","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0528_CR99","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(04)17058-X","volume":"364","author":"SA Naser","year":"2004","unstructured":"Naser SA et al. (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364: 1039\u20131044","journal-title":"Lancet"},{"key":"BFncpgasthep0528_CR100","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/gut.2004.045526","volume":"54","author":"F Autschbach","year":"2005","unstructured":"Autschbach F et al. (2005) High prevalence of Mycobacterium avium subsp. paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 54: 944\u2013999","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR101","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1751-0813.2004.tb12685.x","volume":"82","author":"TF Jubb","year":"2004","unstructured":"Jubb TF and Galvin JW (2004) Effect of a test and control program for bovine Johne's disease in Victorian dairy herds 1992\u20132002. Aust Vet J 82: 228\u2013232","journal-title":"Aust Vet J"},{"key":"BFncpgasthep0528_CR102","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3168\/jds.S0022-0302(04)73427-X","volume":"87","author":"EA Raizman","year":"2004","unstructured":"Raizman EA et al. (2004) The distribution of Mycobacterium avium ssp. paratuberculosis in the environment surrounding Minnesota dairy farms. J Dairy Sci 87: 2959\u20132966","journal-title":"J Dairy Sci"},{"key":"BFncpgasthep0528_CR103","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0168-1605(02)00057-0","volume":"77","author":"BM Lund","year":"2002","unstructured":"Lund BM et al. (2002) Pasteurization of milk and the heat resistance of Mycobacterium avium subsp. paratuberculosis: a critical review of the data. Int J Food Microbiol 77: 135\u2013145","journal-title":"Int J Food Microbiol"},{"key":"BFncpgasthep0528_CR104","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","volume":"127","author":"A Darfeuille-Michaud","year":"2004","unstructured":"Darfeuille-Michaud A et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412\u2013421","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR105","unstructured":"Peeters H et al. CARD15 variants determine a disturbed response of monocytes to adherent-invasive Escherichia coli LF82 in Crohn 2019's disease [abstract]. Ann NY Acad Sci, in press"},{"key":"BFncpgasthep0528_CR106","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/0016-5085(95)90687-8","volume":"108","author":"Y Liu","year":"1995","unstructured":"Liu Y et al. (1995) Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108: 1396\u20131404","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1078\/1438-4221-00201","volume":"292","author":"A Darfeuille-Michaud","year":"2002","unstructured":"Darfeuille-Michaud A (2002) Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 292: 185\u2013193","journal-title":"Int J Med Microbiol"},{"key":"BFncpgasthep0528_CR108","unstructured":"Huycke MM et al. Superoxide production by Enterococcus faecalis upregulates NTN1 oncogene in the colonic epithelium and alters inflammation-associated gene expression [abstract]. Ann NY Acad Sci, in press"},{"key":"BFncpgasthep0528_CR109","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/01.MIB.0000174374.83601.86","volume":"11","author":"K Erichsen","year":"2005","unstructured":"Erichsen K et al. (2005) Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 11: 744\u2013748","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR110","first-page":"A362","volume":"130","author":"A Lerner","year":"2006","unstructured":"Lerner A et al. (2006) Bacterial\u2013aluminum interactions. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice [abstract]. Gastroenterology 130: A362","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR111","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","volume":"128","author":"RW Summers","year":"2005","unstructured":"Summers RW et al. (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825\u2013832","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR112","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/gut.2004.041749","volume":"54","author":"RW Summers","year":"2005","unstructured":"Summers RW et al. (2005) Trichuris suis therapy in Crohn's disease. Gut 54: 87\u201390","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR113","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/eji.200324833","volume":"34","author":"DE Elliott","year":"2004","unstructured":"Elliott DE et al. (2004) Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34: 2690\u20132698","journal-title":"Eur J Immunol"},{"key":"BFncpgasthep0528_CR114","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1023\/A:1005541700805","volume":"45","author":"BK Korzenik JR and Dieckgraefe","year":"2000","unstructured":"Korzenik JR and Dieckgraefe BK (2000) Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 45: 1121\u20131129","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep0528_CR115","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa041109","volume":"352","author":"JR Korzenik","year":"2005","unstructured":"Korzenik JR et al. (2005) Sargramostim for active Crohn's disease. N Engl J Med 352: 2193\u20132201","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0528_CR116","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1196\/annals.1309.030","volume":"1029","author":"F Powrie","year":"2004","unstructured":"Powrie F (2004) Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann NY Acad Sci 1029: 132\u2013141","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl 1","key":"BFncpgasthep0528_CR117","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/00054725-200402001-00005","volume":"10","author":"CO Elson","year":"2004","unstructured":"Elson CO et al. (2004) Gene disruption and immunity in experimental colitis. Inflamm Bowel Dis 10 (Suppl 1): S25\u2013S28","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR118","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/00054725-200409000-00027","volume":"10","author":"M Allez","year":"2004","unstructured":"Allez M and Mayer L (2004) Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis 10: 666\u2013676","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0528_CR119","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"W Bouma G and Strober","year":"2003","unstructured":"Bouma G and Strober W (2003). The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521\u2013533","journal-title":"Nat Rev Immunol"},{"key":"BFncpgasthep0528_CR120","doi-asserted-by":"publisher","first-page":"900","DOI":"10.4049\/jimmunol.168.2.900","volume":"168","author":"IJ Fuss","year":"2002","unstructured":"Fuss IJ et al. (2002) The interrelated roles of TGF-\u03b2 and IL-10 in the regulation of experimental colitis. J Immunol 168: 900\u2013908","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR121","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1053\/j.gastro.2004.03.076","volume":"126","author":"TA Kraus","year":"2004","unstructured":"Kraus TA et al. (2004) Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126: 1771\u20131778","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR122","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1172\/JCI12821","volume":"108","author":"G Monteleone","year":"2001","unstructured":"Monteleone G et al. (2001) Blocking Smad7 restores TGF-\u03b21 signaling in chronic inflammatory bowel disease. J Clin Invest 108: 601\u2013609","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR123","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.179.2.589","volume":"179","author":"F Powrie","year":"1994","unstructured":"Powrie F et al. (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179: 589\u2013600","journal-title":"J Exp Med"},{"key":"BFncpgasthep0528_CR124","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","volume":"170","author":"C Mottet","year":"2003","unstructured":"Mottet C et al. (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939\u20133943","journal-title":"J Immunol"},{"key":"BFncpgasthep0528_CR125","unstructured":"Albright C et al. (2002) Endogenous IL-10 inhibits APC stimulation of T lymphocyte responses to luminal bacteria [abstract]. Gastroenterology 122: A270"},{"key":"BFncpgasthep0528_CR126","first-page":"A232","volume":"130","author":"B Liu","year":"2006","unstructured":"Liu B et al. (2006) IL-10 production by both antigen presenting cells and CD4+ T lymphocytes maintains mucosal homeostasis [abstract]. Gastroenterology 130: A232","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR127","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1103685","volume":"307","author":"S Maeda","year":"2005","unstructured":"Maeda S et al. (2005) Nod2 mutation in Crohn's disease potentiates NF-\u03baB activity and IL-1\u03b2 processing. Science 307: 734\u2013738","journal-title":"Science"},{"key":"BFncpgasthep0528_CR128","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1053\/j.gastro.2003.11.019","volume":"126","author":"D Rachmilewitz","year":"2004","unstructured":"Rachmilewitz D et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520\u2013528","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR129","unstructured":"Anant S et al. Plasmacytoid DCs are critical elements in the response to GM-CSF in the DSS colitis model [abstract]. Ann NY Acad Sci, in press"},{"key":"BFncpgasthep0528_CR130","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1053\/j.gastro.2005.07.057","volume":"129","author":"J Beckwith","year":"2005","unstructured":"Beckwith J et al. (2005) Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129: 1473\u20131484","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR131","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/gut.49.1.35","volume":"49","author":"J Itoh","year":"2001","unstructured":"Itoh J et al. (2001) Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 49: 35\u201341","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR132","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","volume":"6","author":"R Atreya","year":"2000","unstructured":"Atreya R et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat Med 6: 583\u2013588","journal-title":"Nat Med"},{"key":"BFncpgasthep0528_CR133","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1136\/gut.2004.040824","volume":"53","author":"SJ Peppelenbosch MP and van Deventer","year":"2004","unstructured":"Peppelenbosch MP and van Deventer SJ (2004) T cell apoptosis and inflammatory bowel disease. Gut 53: 1556\u20131558","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR134","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I Tiede","year":"2003","unstructured":"Tiede I et al. (2003) CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 111: 1133\u20131145","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0528_CR135","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1136\/gut.2003.037911","volume":"53","author":"J Doering","year":"2004","unstructured":"Doering J et al. (2004) Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 53: 1632\u20131638","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR136","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1053\/gast.2001.28702","volume":"121","author":"A Lugering","year":"2001","unstructured":"Lugering A et al. (2001) Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121: 1145\u20131157","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR137","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.50.2.206","volume":"50","author":"T ten Hove","year":"2002","unstructured":"ten Hove T et al. (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 50: 206\u2013211","journal-title":"Gut"},{"key":"BFncpgasthep0528_CR138","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","volume":"124","author":"JM Van den Brande","year":"2003","unstructured":"Van den Brande JM et al. (2003) Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124: 1774\u20131785","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0528_CR139","first-page":"11","volume-title":"Presented at 9th Annual Coolum Update in Gastroenterology and Hepatology: 2005 June","author":"W Selby","year":"2005","unstructured":"Selby W (2005) Antibiotic therapy for Crohn's disease. Presented at 9th Annual Coolum Update in Gastroenterology and Hepatology: 2005 June 11\u201313; Coolum"}],"container-title":["Nature Clinical Practice Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0528","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpgasthep0528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:03:15Z","timestamp":1684440195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":139,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["BFncpgasthep0528"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0528","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}